American Century Companies’s ResMed RMD Stock Holding History

American Century Companies’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.7M	Sell	56,573 -2,186	-4%	-$545K	0.01%	1369
2025 Q4	$14.2M	Sell	58,759 -23,127	-28%	-$5.91M	0.01%	1307
2025 Q3	$22.4M	Sell	81,886 -94,015	-53%	-$25.7M	0.01%	1085
2025 Q2	$45.4M	Buy	175,901 +1,183	+0.7%	+$282K	0.02%	712
2025 Q1	$39.1M	Buy	174,718 +13,349	+8%	+$3.12M	0.02%	729
2024 Q4	$36.9M	Sell	161,369 -19,353	-11%	-$4.66M	0.02%	755
2024 Q3	$44.1M	Buy	180,722 +149,848	+485%	+$33.5M	0.03%	657
2024 Q2	$5.91M	Buy	30,874 +4,639	+18%	+$941K	﹤0.01%	1453
2024 Q1	$5.2M	Buy	26,235 +16,506	+170%	+$3.02M	﹤0.01%	1438
2023 Q4	$1.67M	Sell	9,729 -49,808	-84%	-$7.65M	﹤0.01%	1864
2023 Q3	$8.8M	Buy	59,537 +413	+0.7%	+$74.7K	0.01%	1110
2023 Q2	$12.9M	Sell	59,124 -1,912	-3%	-$426K	0.01%	951
2023 Q1	$13.4M	Sell	61,036 -1,730	-3%	-$375K	0.01%	903
2022 Q4	$13.1M	Buy	62,766 +9,191	+17%	+$2.02M	0.01%	872
2022 Q3	$11.7M	Sell	53,575 -32	-0.1%	-$7.28K	0.01%	836
2022 Q2	$11.2M	Buy	53,607 +6,638	+14%	+$1.41M	0.01%	866
2022 Q1	$11.4M	Buy	46,969 +981	+2%	+$237K	0.01%	869
2021 Q4	$12M	Buy	45,988 +776	+2%	+$201K	0.01%	831
2021 Q3	$11.9M	Buy	45,212 +6,940	+18%	+$1.9M	0.01%	797
2021 Q2	$9.44M	Sell	38,272 -11,882	-24%	-$2.5M	0.01%	832
2021 Q1	$9.73M	Buy	50,154 +10,619	+27%	+$2.13M	0.01%	782
2020 Q4	$8.4M	Sell	39,535 -9,614	-20%	-$1.92M	0.01%	791
2020 Q3	$8.43M	Sell	49,149 -26,629	-35%	-$4.92M	0.01%	740
2020 Q2	$14.5M	Sell	75,778 -13,273	-15%	-$2.17M	0.01%	592
2020 Q1	$13.1M	Sell	89,051 -484,090	-84%	-$77.1M	0.02%	538
2019 Q4	$88.8M	Sell	573,141 -18,287	-3%	-$2.64M	0.08%	256
2019 Q3	$79.9M	Sell	591,428 -159,476	-21%	-$20.9M	0.08%	278
2019 Q2	$91.6M	Buy	750,904 +83,841	+13%	+$9.29M	0.09%	267
2019 Q1	$69.4M	Buy	667,063 +658,556	+7,741%	+$68M	0.07%	308
2018 Q4	$969K	Hold	8,507	–	–	﹤0.01%	1055
2018 Q3	$981K	Buy	8,507 +1,035	+14%	+$113K	﹤0.01%	1107
2018 Q2	$774K	Buy	+7,472	New	+$756K	﹤0.01%	1136
2017 Q2	–	Sell	-42,032	Closed	-$3.02M	–	1400
2017 Q1	$3.02M	Sell	42,032 -176,779	-81%	-$12.2M	﹤0.01%	979
2016 Q4	$13.6M	Sell	218,811 -389,335	-64%	-$23.8M	0.01%	608
2016 Q3	$39.4M	Buy	608,146 +14,748	+2%	+$982K	0.04%	406
2016 Q2	$37.5M	Buy	593,398 +75,814	+15%	+$4.47M	0.04%	419
2016 Q1	$29.9M	Buy	+517,584	New	+$29.3M	0.03%	447
2014 Q4	–	Sell	-16,216	Closed	-$799K	–	1460
2014 Q3	$799K	Sell	16,216 -7,415	-31%	-$378K	﹤0.01%	1221
2014 Q2	$1.2M	Sell	23,631 -194,416	-89%	-$9.64M	﹤0.01%	1183
2014 Q1	$9.74M	Sell	218,047 -101,404	-32%	-$4.55M	0.01%	721
2013 Q4	$15M	Sell	319,451 -728,419	-70%	-$36.9M	0.02%	590
2013 Q3	$55.3M	Buy	1,047,870 +184,091	+21%	+$8.93M	0.07%	317
2013 Q2	$39M	Buy	+863,779	New	+$41M	0.05%	388

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American Century Companies's RMD Position: Q1 2026 in Review

American Century Companies reduced its ResMed (RMD) stake by 3.7% in Q1 2026, selling an estimated $545K and leaving 56,573 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #1369.

American Century Companies first reported a position in RMD in Q2 2013 and has held it in 43 quarters since. The position peaked at $91.6M in Q2 2019. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

American Century Companies held 56,573 shares of ResMed worth $12.7M as of Q1 2026.
American Century Companies sold 2,186 ResMed shares in Q1 2026, an estimated $545K.
ResMed made up 0.01% of American Century Companies's portfolio in Q1 2026, its #1369 holding.
American Century Companies first reported a position in ResMed in Q2 2013 and has held it in 43 quarters since.
American Century Companies's ResMed position peaked at $91.6M in Q2 2019.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.